Work Here?

Lexington Medical

Work Here?

Claim Your Company

Manufactures and sells surgical stapling systems

Website

Lexington Medical

Work Here?

Claim Your Company

Manufactures and sells surgical stapling systems

Website

About Lexington Medical

Simplify's Rating

Why Lexington Medical is rated

B-

Rated B on Competitive Edge

Rated B on Growth Potential

Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$6.6M

Headquarters

Billerica, Massachusetts

Founded

2013

Overview

Lexington Medical designs and sells surgical stapling systems for bariatric and gastrointestinal surgeries. Their powered stapling systems and endostapling tools close wounds or connect tissues during surgery, and are manufactured in a Massachusetts facility using automation to ensure consistent quality. The company differentiates itself through vertical integration and in-house manufacturing, strong regulatory compliance, and clinically demonstrated benefits. Its goal is to improve surgical outcomes by giving surgeons more control and expanding access to advanced stapling therapies worldwide.

Simplify's Take

What believers are saying

Ampersand investment accelerates innovation, manufacturing scale-up, and global expansion.
Clinical studies prove reduced hospital stays in gastrointestinal surgeries for bariatric centers.
Team from MIT, Harvard, Boston Scientific, and Medtronic drives cutting-edge stapling advancements.

What critics are saying

Intuitive Surgical's da Vinci 5 erodes 60-80% market share in 12-24 months.
Medtronic TriStaple gains 25% thoracic adoption in 6-12 months via superior leak data.
Ampersand forces Ethicon acquisition in 12-18 months, ending independence.

What makes Lexington Medical unique

AEON Endostapler excels in thoracic, bariatric, and GI surgeries by reducing pancreatic fistula leaks.
Vertical integration with Massachusetts automation ensures superior quality and physician responsiveness.
FDA-cleared Powered Stapling System launched May 2024 delivers optimized surgical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$6.6M

Above

Industry Average

Funded Over

0 Rounds

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

S&P Global

Apr 17th, 2025

Fortitude, Eka Exit Run Buddy Deal

Fortitude Capital LLC and Eka Ventures LLP are exiting The Run Buddy Ltd., developer of the Runna app, as it is set to be acquired by Strava Inc. Meanwhile, Clear Peak Management LLC has invested in Ntara Partners Inc., a provider of product experience management consulting and solutions. Additionally, Ampersand Management LLC has invested in medical device manufacturer Lexington Medical Inc.

PR Newswire

Apr 17th, 2025

Lexington Medical Gains Ampersand Investment

Lexington Medical announced a strategic growth investment from Ampersand Capital Partners, a private equity firm specializing in healthcare and life sciences. This partnership aims to accelerate Lexington's innovation, manufacturing, and global expansion in surgical stapling solutions. The investment highlights Ampersand's confidence in Lexington's potential to redefine industry standards. Interested candidates can explore career opportunities at www.lexington-med.com/careers.

Recently Posted Jobs